Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Neuroscience ; 319: 35-45, 2016 Apr 05.
Artigo em Inglês | MEDLINE | ID: mdl-26812038

RESUMO

Activation of P2X7 receptor (P2X7R), a purinergic receptor, expressed by neurons is well-known to induce their death, but whether or not their sensitivity to ATP depends on its expression levels remains unclear. Here, we examined the effect of the expression level of P2X7Rs on cell viability using pure neuron cultures, co-cultures with astrocytes derived from SJL- and ddY-strain mice, and mouse P2X7R-expressing HEK293T cell systems. Treatment of pure neuron cultures with 5mM ATP for 2h, followed by 3-h incubation in fresh medium, resulted in death of both types of neurons, and their death was prevented by administration of P2X7R-specific antagonists. In both SJL- and ddY-neurons, ATP-induced neuronal death was inhibited by a mitochondrial permeability transition pore inhibitor cyclosporine A, mitochondrial dysfunction being involved in their death. The ATP-induced neuronal death was greater for SJL-neurons than for ddY-ones, this being correlated with the expression level of P2X7R in them, and the same results were obtained for the HEK293T cell systems. Co-culture of neurons with astrocytes increased the ATP-induced neuronal death compared to the case of pure neuron cultures. Overall, we reveal that neuronal vulnerability to ATP depends on the expression level of P2X7R, and co-existence of astrocytes exacerbates ATP-induced neuronal death.


Assuntos
Trifosfato de Adenosina/farmacologia , Morte Celular/fisiologia , Neurônios/metabolismo , Receptores Purinérgicos P2X7/metabolismo , Animais , Astrócitos/metabolismo , Western Blotting , Morte Celular/efeitos dos fármacos , Células Cultivadas , Técnicas de Cocultura , Células HEK293 , Humanos , Imuno-Histoquímica , Camundongos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/patologia , Neurônios/efeitos dos fármacos , Reação em Cadeia da Polimerase
2.
J Hypertens ; 9(4): 337-44, 1991 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-1646260

RESUMO

The effects of low-dose endothelin on systemic haemodynamics and vasoactive hormones were examined in conscious dogs. In addition, we examined the effects of endothelin on pressor responses to noradrenaline and angiotensin II and the baroreflex regulation of heart rate in conscious dogs. Continuous infusion of 40 fmol/kg per min endothelin for 40 min induced a mild but significant reduction in mean arterial pressure from 89.1 +/- 1.7 to 82.7 +/- 2.0 mmHg (P less than 0.05), associated with decreases in total peripheral resistance 20 min later. A 400 fmol/kg per min dose of endothelin, on the other hand, induced a gradual elevation of mean arterial pressure from 89.2 +/- 2.3 to 96.8 +/- 2.0 mmHg (P less than 0.05), associated with increases in total peripheral resistance over 30 min. The 40 fmol/kg per min dose of endothelin infusion induced a significant reduction in plasma arginine vasopressin (AVP; P less than 0.05) and elevations of plasma atrial natriuretic peptide (ANP; P less than 0.05), plasma prostaglandin E2 (PGE2; P less than 0.05) and plasma 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha; P less than 0.05). The 400 fmol/kg per min dose produced elevations of AVP, ANP, PGE2 and 6-keto-PGF1 alpha (P less than 0.05). Pressor responses to noradrenaline and angiotensin II were significantly attenuated during continuous infusion of 40 fmol/kg per min endothelin, whereas 400 fmol/kg per min endothelin did not induce any significant changes compared with the control. Furthermore, baroreflex sensitivity was attenuated with 40 fmol/kg per min endothelin but did not show any significant changes at 400 fmol/kg per min.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Endotelinas/farmacologia , Hemodinâmica/efeitos dos fármacos , Hormônios/sangue , Angiotensina II/farmacologia , Animais , Arginina Vasopressina/sangue , Fator Natriurético Atrial/sangue , Pressão Sanguínea/efeitos dos fármacos , Estado de Consciência , Cães , Endotelinas/administração & dosagem , Masculino , Norepinefrina/farmacologia , Pressorreceptores/efeitos dos fármacos , Reflexo/efeitos dos fármacos , Sistema Vasomotor/efeitos dos fármacos
3.
J Hypertens ; 10(6): 561-9, 1992 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-1320077

RESUMO

OBJECTIVE: The aim of this study was to investigate the role of depressor systems in glucocorticoid-induced hypertension. METHODS: The serial changes in cardiorenal hemodynamics, urinary excretions of kallikrein and prostaglandins (PGE2 and the prostacyclin derivative 6-keto-PGF1 alpha) before, and during the administration of both low and high doses of dexamethasone (9 alpha-fluoro-16 alpha-methylprednisolone) and after the cessation of dexamethasone were examined in conscious trained dogs. In addition, pressor responses to prostaglandin, bradykinin, bradykinin antagonist and indomethacin were studied during the administration of dexamethasone. RESULTS: High-dose dexamethasone induced a significant elevation in mean arterial pressure (MAP) that was accompanied by a significant reduction in the urinary excretion of kallikrein, PGE2 and 6-keto-PGF1 alpha. In contrast, low-dose dexamethasone treatment had no significant effect upon MAP but induced a transient elevation in the urinary excretion of kallikrein, PGE2 and 6-keto-PGF1 alpha. Furthermore, additional oral administration of indomethacin produced a significant elevation in MAP in dogs treated with low-dose dexamethasone; but did not affect the hemodynamics of animals with high-dose dexamethasone. Whilst i.v. administration of either bradykinin or prostacyclin induced a significant reduction in MAP in high-dose but not low-dose dexamethasone-treated dogs, administration of a competitive bradykinin antagonist, D-Arg-[Hyp3, Thi5,8, D-Phe7]-bradykinin induced a significant elevation in MAP in low-dose but not high-dose dexamethasone-treated dogs. CONCLUSION: Depressor systems play an important role in regulation of blood pressure in glucocorticoid-treated dogs.


Assuntos
Pressão Sanguínea/efeitos dos fármacos , Glucocorticoides/administração & dosagem , Hipertensão/etiologia , Animais , Pressão Sanguínea/fisiologia , Bradicinina/administração & dosagem , Bradicinina/análogos & derivados , Dexametasona/administração & dosagem , Cães , Relação Dose-Resposta a Droga , Interações Medicamentosas , Hipertensão/fisiopatologia , Indometacina/administração & dosagem , Sistema Calicreína-Cinina/efeitos dos fármacos , Sistema Calicreína-Cinina/fisiologia , Masculino , Prostaglandinas/fisiologia , Fatores de Tempo
4.
Keio J Med ; 48(1): 1-11, 1999 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10206013

RESUMO

As the population ages and more expensive high-technology services become available, health care costs continue to spiral upward. Because the financial resources for health care are limited, economic analysis can help to evaluate expenditures and set priorities. Economic analysis of medical technology or medical care evaluates a medical service by comparing its dollar cost with its dollar benefit (cost-benefit), by measuring its dollar cost in relation to its outcomes (cost-effectiveness) as well as in relation to its utility or quality-adjusted outcomes (cost-utility), or simply by tabulating the costs involved (cost-identification). Direct costs are generated as services are provided. In addition, patients' productivity is affected, and these costs can be considered, especially in determining the benefit of a service that decreases morbidity or mortality. Intangible costs are those of pain, suffering, and grief. The point of view, or perspective, of the study determines the costs and benefits that will be measured in the analysis. Sensitivity analysis, which can evaluate the stability of the conclusions to the data used, is an important assessment within economic analysis. Economic analysis of new pharmaceutical therapies is increasingly being incorporated into clinical trials. Although there are some limitations of pharmacoeconomic information in clinical studies of drug safety and efficacy, these trials are often the only opportunity for economic data collection before adoption and reimbursement decisions are made. Validation after the drug has been introduced should complement economic information developed from clinical trials.


Assuntos
Ensaios Clínicos como Assunto/economia , Avaliação de Processos e Resultados em Cuidados de Saúde , Custos e Análise de Custo , Humanos , Japão
5.
Clin Nephrol ; 56(2): 96-103, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11522101

RESUMO

BACKGROUND: A multicenter prospective clinical trial was carried out in 9 National Hospitals in Japan to elucidate the time-dependent change in urinary Type IV collagen excretion rate of Type II diabetes mellitus (DM) patients, and to investigate whether an angiotensin-converting enzyme inhibitor (ACE-I) or probucol is effective in preventing progression of renal involvement of diabetics by evaluating urinary Type IV collagen excretion. METHODS: Normo- and microalbuminuric patients with Type II DM were recruited. Patients were assigned to either the control (n = 88), ACE-I (n = 43) or probucol (n = 37) group and treated for 24 months. Besides albumin excretion rate (AER), urinary Type IV collagen excretion rate was also measured. RESULTS: Although, AER, urinary N-acetyl-beta-D-glucosaminidase and beta2-microglobulin excretion rates in the control group did not vary over 24 months, urinary Type IV collagen excretion rate in the control group increased time-dependently (p < 0.01 vs baseline at 18 months and p < 0.005 vs baseline at 24 months). In the ACE-I and probucol groups, time-dependent increases in urinary Type IV collagen excretion rates were not observed. In the ACE-I group, the urinary Type IV collagen excretion rate was significantly lower than that in the control group at 24 months (p < 0.05). In the probucol group, the urinary Type IV collagen excretion rate was significantly lower than that in the control group at 6 months (p < 0.05). In the ACE-I group, AER decreased significantly compared with baseline at 18 months (p < 0.05) and at 24 months (p < 0.005). CONCLUSIONS: ACE-I has a beneficial effect and probucol may have a beneficial effect in preventing the progression of early diabetic nephropathy. Measurement of the urinary Type IV collagen excretion rate in combination with AER would be useful for the management of early renal involvement in Type II DM.


Assuntos
Albuminúria/tratamento farmacológico , Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Antioxidantes/uso terapêutico , Colágeno Tipo IV/urina , Diabetes Mellitus Tipo 2/urina , Nefropatias Diabéticas/tratamento farmacológico , Probucol/uso terapêutico , Acetilglucosaminidase/urina , Adulto , Idoso , Antioxidantes/farmacologia , Colesterol/sangue , Diabetes Mellitus Tipo 2/sangue , Diabetes Mellitus Tipo 2/complicações , Nefropatias Diabéticas/etiologia , Nefropatias Diabéticas/urina , Feminino , Hemoglobinas Glicadas/análise , Humanos , Masculino , Pessoa de Meia-Idade , Probucol/farmacologia , Estudos Prospectivos , Fatores de Tempo
6.
Intern Med ; 40(5): 409-13, 2001 May.
Artigo em Inglês | MEDLINE | ID: mdl-11393412

RESUMO

A 60-year-old man was diagnosed as adult T-cell leukemia with severe hypercalcemia because of production of parathyroid hormone-related protein. After admission, the patient had respiratory insufficiency with an infiltrative shadow in his lungs suggestive of pneumonia. However, neither improvement in respiratory function nor disappearance of the abnormal chest shadow was observed with administration of various antibiotics. An autopsy demonstrated the chest shadow had been caused by metastatic calcification associated with hypercalcemia due to production of parathyroid hormone-related protein. The possibility of metastatic calcification should be considered in patients with adult T-cell leukemia and hypercalcemia who have an abnormal chest shadow.


Assuntos
Calcinose/etiologia , Hipercalcemia/complicações , Leucemia de Células T/complicações , Pneumopatias/etiologia , Biossíntese de Proteínas , Calcinose/diagnóstico , Humanos , Pneumopatias/diagnóstico , Masculino , Pessoa de Meia-Idade , Proteína Relacionada ao Hormônio Paratireóideo , Radiografia Torácica
7.
Intern Med ; 33(8): 488-91, 1994 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7803917

RESUMO

A 69-year-old female was admitted to our hospital because of leg edema, proteinuria (2.1 g/day), and gross hematuria. She had non-alcoholic liver cirrhosis of unknown etiology. Esophageal varices also were found. Examination of the renal biopsy specimen revealed mesangial proliferative glomerulonephritis with IgA deposits. Propranolol was administered orally to reduce portal hypertension, resulting in a progressive decrease in urinary microalbumin excretion. This case suggests that portal hypertension is involved in the pathogenesis of IgA nephropathy in liver cirrhosis.


Assuntos
Glomerulonefrite por IGA/etiologia , Hepatite/complicações , Hipertensão Portal/etiologia , Cirrose Hepática/etiologia , Idoso , Feminino , Glomerulonefrite por IGA/patologia , Hepatite/patologia , Humanos , Hipertensão Portal/tratamento farmacológico , Hipertensão Portal/patologia , Glomérulos Renais/ultraestrutura , Cirrose Hepática/patologia , Microscopia Eletrônica , Propranolol/uso terapêutico
8.
J Nutr Sci Vitaminol (Tokyo) ; 35(6): 613-26, 1989 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-2534519

RESUMO

The effects of methyl-group acceptors such as glycine, guanidinoacetic acid, and nicotinamide on cholesterol metabolism and phosphatidylcholine(PC) biosynthesis were investigated with rats fed a 25% casein diet containing cholesterol with or without methionine supplement. The effect of ethanolamine, an indirect methyl-group acceptor via phosphatidylethanolamine(PE) formation, was also compared with those of methyl-group acceptors. The methyl-group acceptors and ethanolamine decreased or tended to decrease plasma total cholesterol level when added to the 25% casein diet. These compounds also significantly depressed the methionine-induced enhancement of plasma cholesterol level. The activity of PE N-methyltransferase was decreased by the addition of glycine, guanidinoacetic acid, and nicotinamide, but not ethanolamine, to the reaction mixture when assayed using the postmitochondrial fraction of liver homogenate, suggesting that PE N-methyltransferase activity can be depressed by glycine N-methyltransferase, guanidinoacetic acid N-methyltransferase, and nicotinamide N-methyltransferase systems. The PE N-methyltransferase activity in liver microsomes, however, did not decrease in response to the dietary addition of methyl-group acceptors. The in vitro incorporation of [CH3-14C]methionine into PC of liver slices was also significantly inhibited by the addition of glycine and nicotinamide, but not guanidinoacetic acid and ethanolamine, to the incubation medium. It is suggested that methyl-group acceptors can decrease plasma cholesterol level at least in part through the depression of PC biosynthesis via PE N-methylation pathway, and that the mechanism for the plasma cholesterol-lowering effect of ethanolamine is different from that of methyl-group acceptors.


Assuntos
Colesterol na Dieta/administração & dosagem , Colesterol/sangue , Glicina/análogos & derivados , Glicina/farmacologia , Niacinamida/farmacologia , Animais , Ácidos e Sais Biliares/metabolismo , Caseínas/administração & dosagem , Colesterol na Dieta/farmacologia , Proteínas Alimentares/administração & dosagem , Etanolamina , Etanolaminas/farmacologia , Fezes , Metabolismo dos Lipídeos , Fígado/anatomia & histologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Metionina/administração & dosagem , Metionina/farmacologia , Metiltransferases/metabolismo , Microssomos Hepáticos/enzimologia , Tamanho do Órgão/efeitos dos fármacos , Fosfatidiletanolamina N-Metiltransferase , Ratos , Ratos Endogâmicos
9.
Jpn J Antibiot ; 39(1): 127-32, 1986 Jan.
Artigo em Japonês | MEDLINE | ID: mdl-3457962

RESUMO

Twenty patients who were performed pulmonary resection for the disease of the lung were administered 2 g of cefmenoxime (CMX) intravenously during the operation. The CMX levels in serum, lung tissue and thoracic muscle were measured by agar-well technique. The CMX levels in lung tissue and thoracic muscle were higher than the MIC80 of CMX for Klebsiella pneumoniae, Haemophilus influenzae and Streptococcus pneumoniae which were commonly as isolated causative organisms from the patients with pulmonary infection. These results indicate that CMX will be useful agent for the prevention and treatment of pulmonary infection.


Assuntos
Cefotaxima/análogos & derivados , Pneumopatias/cirurgia , Pulmão/metabolismo , Músculos Peitorais/metabolismo , Adolescente , Adulto , Idoso , Infecções Bacterianas/prevenção & controle , Cefmenoxima , Cefotaxima/administração & dosagem , Cefotaxima/metabolismo , Feminino , Humanos , Injeções Intravenosas , Cinética , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias/prevenção & controle
10.
Fukushima J Med Sci ; 44(1): 13-21, 1998 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9775527

RESUMO

We attempted to construct the contour of recurrence in primary lung adenocarcinoma with clinicopathologic variables based on data of 131 patients with completely resected primary lung adenocarcinoma. In univariate analysis, tumor size (more or less 3 cm in diameter), p-T, p-N, pathological stage, differentiation, ly factor and v factor were chosen for prognostic predictors. In multivariate analysis, v factor and p-N were independent variables of local recurrence and metastatic recurrence, respectively. The examination of significant correlation among clinicopathologic variables in terms of 5-year survival rates of patients showed that tumor size, p-T, ly factor and v factor were profoundly related to local recurrence, whereas ly factor, differentiation and p-N were linked to distant metastasis. We therefore examined an additive effect of tumor size, differentiation and vascular invasion on recurrence. The results demonstrated that neither local nor metastatic recurrences were found in patients with well differentiated adenocarcinoma less than 3 cm in diameter if vascular invasion was negative. We conclude that vascular (ly factor and v factor) is central to lung adenocarcinoma recurrence. The vascular invasion is a powerful predictor of recurrence in less than 3 cm diameter, well differentiated adenocarcinoma of the lung.


Assuntos
Adenocarcinoma/patologia , Neoplasias Pulmonares/patologia , Recidiva Local de Neoplasia/patologia , Adenocarcinoma/mortalidade , Adulto , Idoso , Feminino , Humanos , Neoplasias Pulmonares/mortalidade , Masculino , Pessoa de Meia-Idade , Metástase Neoplásica , Taxa de Sobrevida
11.
Nihon Jinzo Gakkai Shi ; 38(8): 388-92, 1996 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-8828359

RESUMO

We report a patient with rhabdomyolysis secondary to hyperosmolar nonketotic diabetic coma (HNKC), who progressed to acute renal failure. A 43-year-old male with diabetes mellitus for three years was admitted to our hospital because of loss of consciousness. The laboratory findings at admission were as follows: serum glucose 1792 mg/dl, serum Na 129 mEq/1, BUN 71 mg/d1, serum creatinine 3.3 mg/d1, CPK 715 IU/1, plasma osmolality 370 mOsm/1, and negative urine ketone bodies. A diagnosis of HNKC was made. On the 2nd day, he had oliguria and the serum creatinine increased despite adequate treatment of HNKC by the administration of intravenous fluid and insulin. On the 4th day, CPK reached 47,300 IU/1, and serum myoglobin was also increased, indicating rhabdomyolysis. His renal function improved gradually and was almost normalized on the 20th day. Renal biopsy on the 23rd day showed myoglobin at the distal renal tubules, which appeared to be involved in the pathogenesis of renal failure by rhabdomyolysis. However, we found little abnormality association with diabetic nephropathy in the renal tissue. Since HNKC is known to induce acute renal failure rarely without diabetic nephropathy, these findings suggested that the acute renal failure was caused mainly by the rhabdomyolysis. Acute renal failure induced by rhabdomyolysis in patients with HNKC is rare, but fatal. The present study showed that the measurement of serum CPK and urine myoglobin was helpful for early diagnosis. Only 12 cases have been reported to have developed renal failure due to rhabdomyolysis among patients with HNKC. To our knowledge, we demonstrated for the first time that myoglobin at the distal renal tubules after renal function was normalized.


Assuntos
Injúria Renal Aguda/etiologia , Coma Hiperglicêmico Hiperosmolar não Cetótico/complicações , Túbulos Renais Distais/química , Mioglobina/análise , Rabdomiólise/complicações , Adulto , Humanos , Masculino , Rabdomiólise/diagnóstico
12.
Gan To Kagaku Ryoho ; 15(4 Pt 2-1): 899-902, 1988 Apr.
Artigo em Japonês | MEDLINE | ID: mdl-3389832

RESUMO

The effectiveness of extended dissection of higher-ranked lymph nodes in patients with rectal cancer has been well recognized recently. However, to prevent postoperative bladder and sexual dysfunction, reduced lymphadenectomy and autonomic nerve preservation are necessary. By definition a reduced operation for rectal cancer attempts to preserve the autonomic nerve and the levator ani muscles without hampering recovery. To clarify the indication of reduced operation for rectal cancer, 219 patients with rectal cancer who underwent resections at our hospital between 1980 and 1986 were analyzed. The relationship of the depth of tumor invasion through the bowel wall to lymph node metastasis in rectal cancer was examined. In cases of rectal cancer limited to submucosa or muscularis propria, the degree of metastatic spread was n0 or n1 (+). In the cases of rectal cancer invading subserosa, serosa or contiguous structures, the degree of metastatic spread was n3(+) or n4(+). Concerning the relationship of the histopathological type and 5-year survival rate, the corrected 5-year survival rate was 72.46% in cases of well and moderately differentiated adenocarcinoma, and 48.84% in cases of poorly differentiated adenocarcinoma and undifferentiated carcinoma. From these results, reduced lymph node dissection and autonomic nerve preservation are possible in patients with well and moderately differentiated adenocarcinoma with invasion into the mucosa, submucosa and muscularis propria.


Assuntos
Neoplasias Retais/cirurgia , Humanos , Métodos , Prognóstico , Neoplasias Retais/patologia , Estudos Retrospectivos
13.
Gan To Kagaku Ryoho ; 26(7): 927-32, 1999 Jun.
Artigo em Japonês | MEDLINE | ID: mdl-10396319

RESUMO

Clinical study has been conducted to evaluate the efficacy of chemotherapy with docetaxel and cisplatin in six patients with advanced non-small cell lung cancer. Treatment schedule consisted of docetaxel 60 mg/m2 and cisplatin 80 mg/m2 on day 1 and repeated every 4 weeks. Eligible patients had histologically proven locally advanced or metastatic non-small cell lung cancer, PS < or = 2, age < or = 74, normal hematological, hepatic and renal functions and informed consent in writing. Six patients have been included; all were males, median age 64 (range 47-74), histology; adenocarcinoma 4, squamous cell carcinoma 2, stage III B 4, stage IV 2. Among these 6 patients, 3 PR (50%) were observed. Neutropenia was the most common adverse event (83%). The lowest granulocyte counts were most frequently seen on day 9.4 (range: 6-14). Non hematologic adverse events included alopecia (6 cases), general fatigue (5 cases), anorexia (5 cases) and emesis (3 cases). These events were recovered rapidly with no therapy. The results suggest that combination chemotherapy of docetaxel and cisplatin will be effective and safe under careful observation.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Neoplasias Pulmonares/tratamento farmacológico , Taxoides , Adenocarcinoma/tratamento farmacológico , Idoso , Carcinoma de Células Escamosas/tratamento farmacológico , Cisplatino/administração & dosagem , Docetaxel , Esquema de Medicação , Avaliação de Medicamentos , Fator Estimulador de Colônias de Granulócitos/administração & dosagem , Humanos , Masculino , Pessoa de Meia-Idade , Paclitaxel/administração & dosagem , Paclitaxel/análogos & derivados
14.
Nihon Geka Gakkai Zasshi ; 92(10): 1503-8, 1991 Oct.
Artigo em Japonês | MEDLINE | ID: mdl-1961188

RESUMO

After pneumonectomy, it is recognized that the absolute reduction of the pulmonary vascular bed makes the right ventricular afterload increase and can cause right heart failure in patients with low cardiopulmonary reserve. Therefore, we investigated how the right ventricular load was predicted by UPAO test, comparing hemodynamics at the time of the test with those after pneumonectomy in patients with lung cancer. At the test, the absolute reduction of the pulmonary vascular bed made the right ventricular afterload increase but the right ventricular pump function was maintained at the preoperative level by the increase of the right ventricular work load, namely, by the contraction of the right ventricle. After pneumonectomy, the absolute reduction of the vascular bed did not always make the afterload increase and in spite of the decreased preload the pump function was maintained at the preoperative level by increased heart rate. Additionally, the increase of the right ventricular work load improved during early postoperative days. It was concluded that UPAO test was apt to overestimate the right ventricular load of the postoperative day because it was done under the condition of the different compensatory function from the postoperative hypovolemic change.


Assuntos
Pneumonectomia , Função Ventricular Direita/fisiologia , Idoso , Humanos , Pessoa de Meia-Idade , Artéria Pulmonar/fisiologia
15.
J Perinatol ; 34(8): 636-9, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-25073494

RESUMO

We report herein a case of early vitamin K deficiency bleeding (VKDB) in a neonate associated with maternal Crohn's disease. A female neonate was born at 37 weeks' gestation and weighed 2778 g. She developed broad purpura on her back on day 1. Laboratory data showed anemia, prolonged coagulation time and elevated protein induced by vitamin K absence or antagonist-II. Early VKDB has not been reported in a neonate born from mother with active Crohn's disease. It is essential to give vitamin K selectively as soon as possible after birth to prevent early VKDB in neonates.


Assuntos
Doença de Crohn/complicações , Complicações na Gravidez/terapia , Sangramento por Deficiência de Vitamina K/etiologia , Sangramento por Deficiência de Vitamina K/terapia , Adulto , Doença de Crohn/terapia , Feminino , Humanos , Recém-Nascido , Gravidez , Sangramento por Deficiência de Vitamina K/diagnóstico
18.
J Vet Med A Physiol Pathol Clin Med ; 53(6): 296-9, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16901273

RESUMO

An 8-month-old Japanese Black heifer with severe erythropoietic symptoms was subjected to clinical, histological and cytological examinations. During the 1 month clinical observation period, severe increases in RBC count, packed cell volume and haemoglobin concentration were observed. The plasma erythropoietin (Epo) concentration of the heifer (20.7 mIU/ml) was similar to that observed in normal control heifers. Blood gas examinations of the arterial and venous blood revealed low levels of partial pressure O(2) (PaO(2)), partial pressure CO(2) (PaCO(2)) and O(2) saturation (SaO(2)), while the blood pH was within the normal range. Gross lesions could not be detected. However, microscopic observation revealed severe proliferation of erythroblasts in the bone marrow and in the spleen without evidence of neoplastic changes. Based on these clinical and pathological examinations, we diagnosed the heifer as being the first case of primary erythrocytosis in Japanese Black cattle.


Assuntos
Doenças dos Bovinos/sangue , Doenças dos Bovinos/diagnóstico , Policitemia/veterinária , Animais , Gasometria/veterinária , Bovinos , Doenças dos Bovinos/etiologia , Diagnóstico Diferencial , Evolução Fatal , Feminino , Pressão Parcial , Policitemia/sangue , Policitemia/diagnóstico , Policitemia/etiologia
19.
Jpn Heart J ; 30(6): 917-27, 1989 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2632840

RESUMO

The effects of dietary protein alterations on the synthesis of prostaglandins and kallikrein were examined in subtotally nephrectomized spontaneously hypertensive rats. Three diets containing 40, 24 and 8% protein were prepared. After subtotal nephrectomy, rats were given one of the three diets for the next 12 weeks. During the study, systolic blood pressure, urinary excretions of protein, 6-keto-prostaglandin F1 alpha, thromboxane B2 and kallikrein were measured every 2 weeks. Although the diets did not prevent the further elevation of systolic blood pressure, the rats on the low protein diet displayed lower serum creatinine levels and urinary protein levels. The urinary excretion of thromboxane B2 was unaffected by the amount of dietary protein, but the urinary excretion of 6-keto-prostaglandin F1 alpha was lower in the low protein diet group. Furthermore, the urinary excretion of kallikrein increased significantly in rats on high protein diet. These results suggest that manipulation of dietary protein may alter the natural course of renal failure induced by subtotal nephrectomy in spontaneously hypertensive rats.


Assuntos
Proteínas Alimentares/farmacologia , Hipertensão/metabolismo , Calicreínas/biossíntese , Rim/fisiopatologia , Prostaglandinas/biossíntese , 6-Cetoprostaglandina F1 alfa/urina , Animais , Calicreínas/urina , Nefrectomia , Prostaglandinas/urina , Ratos , Ratos Endogâmicos SHR , Tromboxano B2/urina
20.
Clin Sci (Lond) ; 76(4): 353-6, 1989 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2540931

RESUMO

1. We have investigated the effects of the non-renin-mediated actions of angiotensin converting enzyme inhibitors on the progression of chronic renal failure accelerated by hypertension. For this purpose, we studied the effects of captopril (a thiol-containing angiotensin converting enzyme inhibitor), enalapril (an angiotensin converting enzyme inhibitor without a thiol group) and cysteine (a thiol-containing amino acid which has no angiotensin converting enzyme-inhibitory action) in adriamycin-treated rats with deoxycorticosterone acetate-salt hypertension, in which the renin-angiotensin system was suppressed. 2. There were no significant differences in blood pressure between these groups and the control group [adriamycin-treated group with deoxycorticosterone acetate-salt loading, 206 +/- 7 mmHg (27.4 +/- 0.9 kPa) at week 10]. 3. Massive proteinuria occurred in all groups. At the end of the experiment (at week 10), urinary protein excretion was significantly reduced in the captopril and cysteine groups compared with the control group. No manifest improvements appeared in the enalapril group. 4. Levels of serum creatinine and blood urea nitrogen increased progressively. At week 10, the increases in the serum levels of creatinine were less in the captopril (87 +/- 16 mmol/l) and cysteine (80 +/- 19 mmol/l) groups than in the control group (124 +/- 27 mmol/l) (P less than 0.01). No marked differences were found between the control and enalapril groups. 5. Captopril and cysteine caused more than a three-fold reduction in the focal glomerulosclerosis score when compared with that in the control group, but enalapril did not decrease the score. The extent of tubulointerstitial change was parallel with the focal glomerulosclerosis score. 6. We conclude that the thiol group is possibly involved in the mechanism of the beneficial effects of some angiotensin converting enzyme inhibitors on the progression of chronic renal failure exacerbated by hypertension.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/uso terapêutico , Falência Renal Crônica/tratamento farmacológico , Animais , Captopril/uso terapêutico , Cisteína/uso terapêutico , Enalapril/uso terapêutico , Falência Renal Crônica/fisiopatologia , Masculino , Ratos , Ratos Endogâmicos , Compostos de Sulfidrila
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA